Andrea Matthews
Corporate Officer/Principal bei ASTRIA THERAPEUTICS, INC.
Vermögen: - $ am 31.03.2024
Profil
Andrea L.
Matthews is currently the Chief Business Officer at Astria Therapeutics, Inc. She started this position in 2023.
Prior to her current role, she worked at Selventa, Inc. as the Vice President-Commercial Operations from 2010 to 2014.
Ms. Matthews completed her undergraduate degree at Boston University and holds an MBA from MIT Sloan School of Management.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 08.02.2024 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Andrea Matthews
| Unternehmen | Position | Beginn |
|---|---|---|
| ASTRIA THERAPEUTICS, INC. | Corporate Officer/Principal | 19.04.2023 |
Ehemalige bekannte Positionen von Andrea Matthews
| Unternehmen | Position | Ende |
|---|---|---|
Selventa, Inc.
 Selventa, Inc. Miscellaneous Commercial ServicesCommercial Services Selventa, Inc. develops new approaches for the understanding and treatment of diseases. It focuses on elucidating the complexity of biology for the development of safe and effective therapeutics and molecular diagnostics. The company was founded in 2002 by Keith O. Elliston and Noubar B. Afeyan and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 16.03.2010 |
Ausbildung von Andrea Matthews
| Boston University | Undergraduate Degree |
| MIT Sloan School of Management | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ASTRIA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Selventa, Inc.
Selventa, Inc. Miscellaneous Commercial ServicesCommercial Services Selventa, Inc. develops new approaches for the understanding and treatment of diseases. It focuses on elucidating the complexity of biology for the development of safe and effective therapeutics and molecular diagnostics. The company was founded in 2002 by Keith O. Elliston and Noubar B. Afeyan and is headquartered in Cambridge, MA. | Commercial Services |
